MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Country |
 USA |
IPO year |
2000 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
159 M |
Market Cap[1] |
$ 23 B |
EBITDA (LTM) |
$ -145 M |
P/E (LTM) |
-24.92 |
P/S (LTM) |
5.1 |
EPS (LTM) |
-5.58 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
$ 20.15 | -1.9 % | $ 584 M | Nasdaq Global Market,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Guardant Health
GH
|
$ 118.95 | 0.8 % | $ 14.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 17.11 | -1.55 % | $ 517 M | Nasdaq Global Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 116.78 | 0.18 % | $ 9.63 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Agilent Technologies
A
|
$ 114.96 | 0.15 % | $ 34.9 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 138.23 | -3.02 % | $ 6.46 B | Nasdaq Global Select Market | USA |
 |
Co-Diagnostics
CODX
|
$ 5.07 | 36.66 % | $ 6.74 M | Nasdaq Capital Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
CareDx, Inc
CDNA
|
$ 21.63 | 0.28 % | $ 1.15 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.82 | 1.11 % | $ 8.05 M | Nasdaq Global Select Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 103.0 | 9.03 % | $ 6.95 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 432.8 | 0.63 % | $ 12.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Mettler-Toledo International
MTD
|
$ 1 103.09 | 1.16 % | $ 22.7 B | NYSE,SPB |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 160.3 | 0.91 % | $ 7.95 B | NYSE,SPB | USA |
 |
Personalis
PSNL
|
$ 8.47 | 2.67 % | $ 756 M | Nasdaq Global Select Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
NeoGenomics
NEO
|
$ 9.23 | 1.32 % | $ 1.18 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 19.08 | 0.21 % | $ 427 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 203.19 | -0.25 % | $ 20 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 3.82 | -2.3 % | $ 354 M | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.95 | -0.74 % | $ 25.6 B | NYSE |  Niderland |
 |
Senseonics Holdings
SENS
|
$ 6.34 | 2.92 % | $ 265 M | NYSE American | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Twist Bioscience Corporation
TWST
|
$ 60.57 | 2.95 % | $ 3.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.49 | 2.05 % | $ 5.72 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 259.93 | 1.63 % | $ 21.6 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 448.28 | -0.24 % | $ 169 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.6 | -3.7 % | $ 216 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Neogen Corporation
NEOG
|
$ 8.9 | 0.45 % | $ 1.93 B | Nasdaq Global Select Market,SPB | USA |
 |
Waters Corporation
WAT
|
$ 342.37 | 0.4 % | $ 20.4 B | NYSE,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 195.21 | 0.72 % | $ 21.7 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.